Skip to main content

Table 2 Comparison of clinical outcomes between complete and incomplete revascularization according to the presence of DM

From: Angiographic complete revascularization versus incomplete revascularization in patients with diabetes mellitus

DM population

Complete revascularization (N = 893)

Incomplete revascularization (N = 1110)

HR (95% CI)

p value

Adjusted HRa (95% CI)

p value

POCO

112 (12.6%)

202 (18.3%)

0.65 (0.52–0.83)

 < 0.001

0.70 (0.52–0.93)

0.016

 All-cause death

51 (5.7%)

85 (7.7%)

0.77 (0.54–1.09)

0.142

0.80 (0.51–1.24)

0.322

 Any MI

5 (0.6%)

13 (1.2%)

0.56 (0.20–1.61)

0.285

0.94 (0.26–3.33)

0.922

 Any revascularization

63 (7.3%)

121 (11.3%)

0.60 (0.44–0.83)

0.002

0.62 (0.42–0.91)

0.016

TLF

58 (6.6%)

83 (7.6%)

0.82 (0.58–1.16)

0.265

0.75 (0.49–1.16)

0.195

 Cardiac death

31 (3.5%)

46 (4.2%)

0.81 (0.51–1.30)

0.390

0.69 (0.38–1.26)

0.227

 Target-vessel MI

2 (0.2%)

7 (0.7%)

0.48 (0.10–2.35)

0.361

0.45 (0.03–6.27)

0.552

 Clinically driven TLR

27 (3.1%)

38 (3.6%)

0.81 (0.49–1.35)

0.414

0.77 (0.41–1.45)

0.418

Non-DM population

Complete revascularization (N = 1833)

Incomplete revascularization (N = 1680)

HR (95% CI)

p value

Adjusted HRa (95% CI)

p value

POCO

153 (8.4%)

233 (13.9%)

0.62 (0.50–0.76)

 < 0.001

0.90 (0.69–1.17)

0.423

 All-cause death

53 (2.9%)

89 (5.3%)

0.59 (0.42–0.84)

0.003

1.07 (0.68–1.70)

0.757

 Any myocardial infarction

7 (0.4%)

14 (0.8%)

0.36 (0.14–0.90)

0.028

0.76 (0.21–2.75)

0.677

 Any revascularization

98 (5.4%)

146 (8.8%)

0.63 (0.49–0.81)

 < 0.001

0.84 (0.61–1.16)

0.284

TLF

75 (4.1%)

99 (6.0%)

0.76 (0.56–1.03)

0.081

1.11 (0.75–1.63)

0.611

 Cardiac death

30 (1.7%)

54 (3.3%)

0.53 (0.34–0.84)

0.006

0.94 (0.51–1.73)

0.847

 Target-vessel MI

4 (0.2%)

10 (0.6%)

0.35 (0.11–1.16)

0.085

0.29 (0.04–2.00)

0.213

 Clinically driven TLR

44 (2.4%)

43 (2.6%)

1.07 (0.70–1.64)

0.750

1.28 (0.73–2.23)

0.393

  1. aThe following patient risk factors were included in the multivariate adjusted Cox proportional hazard regression model: age, sex, body mass index, hypertension, hypercholesterolemia, heart failure, chronic kidney disease, family history of CAD, previous cerebrovascular disease, previous peripheral vascular disease, previous MI, ejection fraction, disease extent, lesion characteristics (left main disease, bifurcation, long lesion, small diameter), total stent number, total stent length, and clinical diagnosis
  2. CI, confidence interval; DM, diabetes mellitus; HR, hazard ratio; MI, myocardial infarction; POCO, patient-oriented composite outcome; TLF, target lesion failure; TLR, target lesion revascularization